<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2182-5173</journal-id>
<journal-title><![CDATA[Revista Portuguesa de Medicina Geral e Familiar]]></journal-title>
<abbrev-journal-title><![CDATA[Rev Port Med Geral Fam]]></abbrev-journal-title>
<issn>2182-5173</issn>
<publisher>
<publisher-name><![CDATA[Associação Portuguesa de Medicina Geral e Familiar]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2182-51732022000400400</article-id>
<article-id pub-id-type="doi">10.32385/rpmgf.v38i4.13238</article-id>
<title-group>
<article-title xml:lang="pt"><![CDATA[Tratamento da infeção por Helicobacter pylori nos cuidados de saúde primários: um trabalho de melhoria da qualidade]]></article-title>
<article-title xml:lang="en"><![CDATA[Treatment of helicobacter pylori infection in the primary health care system: quality improvement project]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Cabral]]></surname>
<given-names><![CDATA[Estela]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Costa]]></surname>
<given-names><![CDATA[Ângela]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Oliveira]]></surname>
<given-names><![CDATA[Dinamene]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Lopes]]></surname>
<given-names><![CDATA[Maria João]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Garcia]]></surname>
<given-names><![CDATA[Sofia]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,ACeS Baixo Vouga USF Atlântico Norte ]]></institution>
<addr-line><![CDATA[Gafanha da Nazaré ]]></addr-line>
<country>Portugal</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,ACeS Baixo Vouga USF Senhora de Vagos ]]></institution>
<addr-line><![CDATA[Vagos ]]></addr-line>
<country>Portugal</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,ACeS Baixo Vouga UCSP Águeda V ]]></institution>
<addr-line><![CDATA[Águeda ]]></addr-line>
<country>Portugal</country>
</aff>
<aff id="Af4">
<institution><![CDATA[,ACeS Baixo Vouga USF Leme ]]></institution>
<addr-line><![CDATA[Ílhavo ]]></addr-line>
<country>Portugal</country>
</aff>
<aff id="Af5">
<institution><![CDATA[,ACeS Baixo Vouga UCSP Anadia III ]]></institution>
<addr-line><![CDATA[Anadia ]]></addr-line>
<country>Portugal</country>
</aff>
<pub-date pub-type="pub">
<day>30</day>
<month>08</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="epub">
<day>30</day>
<month>08</month>
<year>2022</year>
</pub-date>
<volume>38</volume>
<numero>4</numero>
<fpage>400</fpage>
<lpage>407</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.pt/scielo.php?script=sci_arttext&amp;pid=S2182-51732022000400400&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.pt/scielo.php?script=sci_abstract&amp;pid=S2182-51732022000400400&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.pt/scielo.php?script=sci_pdf&amp;pid=S2182-51732022000400400&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="pt"><p><![CDATA[Resumo  Introduc&#807;a&#771;o:  Vários regimes de antibioterapia têm sido propostos para tratamento da infeção por Helicobater pylori (Hp) e a escolha de terapêutica adequada deve basear-se nas resistências locais aos antibióticos, com recurso a terapia quádrupla. Pretende-se com este trabalho melhorar a qualidade da prescrição para tratamento das infeções por Hp, de acordo com a NOC, recomendações clínicas mais recentes e perfis de resistência em Portugal.  Materiais e Me&#769;todos: Este é um trabalho de melhoria de qualidade técnico-científica com dois momentos de avaliação interna, em cinco unidades da Zona Centro. Foram considerados todos os utentes com diagnóstico de infeção por Hp num período de três meses antes e após uma breve intervenção sobre as orientações mais atuais no tratamento do Hp. Os dados foram recolhidos do MIM@UF® e SClínico® e tratados em Microsoft Excel® 2016.  Resultados:  Na avaliação obtiveram-se 68 utentes com diagnóstico positivo para Hp. Destes, 65 receberam tratamento para um total de 46% (n=30) com tratamento adequado. No período pós-intervenção foram avaliados 65 utentes com diagnóstico de infeção por Hp. Destes, 62 receberam tratamento para um total de 71% (n=44) com tratamento adequado.  Discussão:  A intervenção traduziu-se numa melhoria da escolha de terapêutica de primeira linha. Houve uma diminuição na escolha da terapêutica tripla, assim como no erro de prescrição.  Conclusão:  Este trabalho evidencia como a intervenção formativa junto dos médicos poderá contribuir para a melhoria da qualidade da prescrição para tratamento da infeção por Hp.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract  Introduction: Several antibiotic therapy regimens have been proposed for the eradication of Helicobacter pylori (Hp). Local resistances should be considered when choosing quadruple therapy. The purpose of this study is to improve the quality of prescriptions for the treatment of Hp infections which is based on local health regulations, most recent international recommendations, and antibiotic resistance in Portugal.  Materials and Methods: This is a technical and scientific quality improvement study, based on a cycle of assessment and improvement implemented in five primary care units in the central region of Portugal. Included in this study were all patients with a diagnosis of Hp infection in a three-month period before and after the intervention, where the most recent recommendations for treatment of Hp were presented. All data was collected from MIM@UF® and SClínico® databases, registered and analyzed with Microsoft Excel® 2016.  Results: An initial analysis returned a total of 68 patients diagnosed with Hp infection. Sixty-five were treated for a total of 46% (n=30) of adequate treatment. A short intervention was carried out and data was again collected from 65 patients with Hp infection. Sixty-two were treated for a total of 71% (n=44) of adequate treatment.  Discussion: The intervention led to an improvement in first-line therapy choices. There was an evident decrease in prescription error, namely, a reduction of triple therapy choice.  Conclusion:  This study shows that an educational intervention designed and offered to clinicians, is fundamental for quality improvement of prescription for Hp infection treatment.]]></p></abstract>
<kwd-group>
<kwd lng="pt"><![CDATA[Helicobacter pylori]]></kwd>
<kwd lng="pt"><![CDATA[Antibiótico]]></kwd>
<kwd lng="pt"><![CDATA[Bismuto]]></kwd>
<kwd lng="pt"><![CDATA[Claritromicina]]></kwd>
<kwd lng="en"><![CDATA[Helicobacter pylori]]></kwd>
<kwd lng="en"><![CDATA[Antibiotic]]></kwd>
<kwd lng="en"><![CDATA[Bismuth]]></kwd>
<kwd lng="en"><![CDATA[Clarithromycin]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sugano]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Tack]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Kuipers]]></surname>
<given-names><![CDATA[EJ]]></given-names>
</name>
<name>
<surname><![CDATA[Graham]]></surname>
<given-names><![CDATA[DY]]></given-names>
</name>
<name>
<surname><![CDATA[El-Omar]]></surname>
<given-names><![CDATA[EM]]></given-names>
</name>
<name>
<surname><![CDATA[Miura]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Kyoto global consensus report on Helicobacter pylori gastritis]]></article-title>
<source><![CDATA[Gut]]></source>
<year>2015</year>
<volume>64</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>1353-67</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Malfertheiner]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Megraud]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Management of Helicobacter pylori infection the Maastricht IV/ Florence consensus report]]></article-title>
<collab>O'Morain CA.Atherton J.Axon AT.Bazzoli F</collab>
<source><![CDATA[Gut]]></source>
<year>2012</year>
<volume>61</volume>
<page-range>646-64</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<collab>Sociedade Portuguesa de Gastrenterologia</collab>
<article-title xml:lang=""><![CDATA[Helicobacter pylori: norma de orientação clínica GE]]></article-title>
<source><![CDATA[Port J Gastroenterology]]></source>
<year>2008</year>
<volume>15</volume>
<page-range>192-4</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[De Francesco]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Bellesia]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Ridola]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Manta]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Zullo]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[First-line therapies for Helicobacter pylori eradication a critical reappraisal of updated guidelines]]></article-title>
<source><![CDATA[Ann Gastroenterol]]></source>
<year>2017</year>
<volume>30</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>373-9</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chey]]></surname>
<given-names><![CDATA[WD]]></given-names>
</name>
<name>
<surname><![CDATA[Leontiadis]]></surname>
<given-names><![CDATA[GI]]></given-names>
</name>
<name>
<surname><![CDATA[Howden]]></surname>
<given-names><![CDATA[CW]]></given-names>
</name>
<name>
<surname><![CDATA[Moss]]></surname>
<given-names><![CDATA[SF]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[ACG clinical guideline treatment of Helicobacter pylori infection]]></article-title>
<source><![CDATA[Am J Gastroenterol]]></source>
<year>2017</year>
<volume>112</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>212-39</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Malfertheiner]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Megraud]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Management of Helicobacter pylori infection the Maastricht V/Florence consensus report]]></article-title>
<collab>O'Morain CA.Gisbert JP.Kuipers EJ.Axon AT</collab>
<source><![CDATA[Gut]]></source>
<year>2017</year>
<volume>66</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>6-30</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Savoldi]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Carrara]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Graham]]></surname>
<given-names><![CDATA[DY]]></given-names>
</name>
<name>
<surname><![CDATA[Conti]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Tacconelli]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prevalence of antibiotic resistance in Helicobacter pylori a systematic review and meta-analysis in World Health Organization regions]]></article-title>
<source><![CDATA[Gastroenterology]]></source>
<year>2018</year>
<volume>155</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>1372-82</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lopo]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Libânio]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Pita]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Dinis-Ribeiro]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Pimentel-Nunes]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Helicobacter pylori antibiotic resistance in Portugal systematic review and meta-analysis]]></article-title>
<source><![CDATA[Helicobacter]]></source>
<year>2018</year>
<volume>23</volume>
<numero>4</numero>
<issue>4</issue>
</nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<collab>O'Connor HJ</collab>
<article-title xml:lang=""><![CDATA[Helicobacter pylori and dyspepsia physicians' attitudes, clinical practice, and prescribing habits]]></article-title>
<source><![CDATA[Aliment Pharmacol Ther]]></source>
<year>2002</year>
<volume>16</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>487-96</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="book">
<collab>Direção-Geral da Saúde</collab>
<source><![CDATA[Supressão ácida: utilização dos inibidores da bomba de protões e das suas alternativas terapêuticas: norma nº 036/2011, de 30/09/2011]]></source>
<year>2011</year>
<publisher-loc><![CDATA[Lisboa ]]></publisher-loc>
<publisher-name><![CDATA[DGS]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="book">
<collab>WONCA</collab>
<source><![CDATA[Classificação internacional de cuidados de saúde primários]]></source>
<year>1999</year>
<edition>2</edition>
<publisher-loc><![CDATA[Lisboa ]]></publisher-loc>
<publisher-name><![CDATA[Administração Central do Sistema de Saúde]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Majumdar]]></surname>
<given-names><![CDATA[SR]]></given-names>
</name>
<name>
<surname><![CDATA[Soumerai]]></surname>
<given-names><![CDATA[SB]]></given-names>
</name>
<name>
<surname><![CDATA[Lee]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Ross-Degnan]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Designing an intervention to improve the management of Helicobacter pylori infection]]></article-title>
<source><![CDATA[Jt Comm J Qual Improv]]></source>
<year>2001</year>
<volume>27</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>405-14</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
